Member Info for Energyshares

Remember I posted this :
Medusa have also been using the services of another company.
https://www.covidrapidexam.com/

I have posted this before that I filled out the contact form and received this reply straight away.

Message:
Hi ?Are you supplying Medusa antigen test by Avacta (Affidx)?If so when and is it being sold in USA?Regards?Bill

Re: Form Submission - Covid Rapid Exam Form

stevecrummey**********

Thanks Bill. We will have FDA approval within 45-60 days.
That was dated 9th Nov 2021

That’s makes it sometime between Christmas Eve & 8th Jan 2022 if Steve is right.

So Tomorrow or Monday :)

BITL
I think the issue with ABDX TT is down to the name change.
Affidx has been running with GAD,but they have waited with ABDX so they can change Cartons, leaflets and HUA on the packaging.

Got a feeling Medusa going to land a massive EU contract.
Look at the size of this Norwegian contract
£332,000,000
Come on Medusa….

https://ted.europa.eu/udl?uri=TED:NOTICE:676707-2021:TEXT:EN:HTML&src=0

Bella I agree, diagnostics will be a great income in the future but Avacta are too small at the moment to try and juggle both businesses.Roche & Abbott do it well because of their size but Avacta are just not big enough at the moment.
Medusa might change that but at the moment Diagnostics is holding back the SP.

LLP I’m the same just want Avacta to be a success.
Just trying to start positive debate while NO News too much negativity at the moment, even with the two fantastic RNS
FDA & HUA

Only way for Avacta to stay independent is to buy smaller company or merge with similar size company.
Otherwise they will get gobbled up.

Selling off Diagnostics would be a good move then they can focus on therapeutics.

No Point has a similar size short on their stock.
You will never stop short market

Avacta board member moves to Point Bio board,
Both companies very close relationship with Bach Biosciences.(Tufts)

A merger between Avacta Therapeutics and Point Bio would be the perfect and quickest way for Avacta to enter the Nasdaq.
Avacta & Point would then be a more stronger entity and could remain independent longer to see some of the pipeline through.

Point Bio MCap
£504 million which is £372m pounds which is pretty close to Avacta MCAP £302m @£1.13

Point have very similar pipeline 2 x phase 3 and 1 x phase 1 and a long list of CanSeek candidates POINT’s CanSEEK™ has been sub-licensed from both Bach Biosciences and Avacta, which has branded the technology as pre | CISION (an Avacta trademark)

Avacta sell off the Diagnostic business and would then be free of the corrupt UK Gov.

To be honest there is a Global shortage of LFT’s, I can’t see major governments and distributors searching the Medusa website and placing orders for millions through the website.
FFS all initial stock manufactured will already be sold in massive numbers to governments world wide.

I think Medusa will be putting all the resources into fulfilling these orders than sending a few boxes to PI’s
Cut them some slack if the website is still like that in a month then have your moan.

For all the Trolls bashing Medusa19 for being too slow.

More than 11 million shares are owned by Clare Hughes, wife of Richard Hughes, co-founder of Zeus Capital, and Mahmud Kamani, co-founder of Boohoo. This shows that there is a lot of confidence in the future capacity of Avacta.

It’s in their interest to push sales of the diagnostics and make as much money as they can for Avacta to expand the Therapeutics and a buy out.

Like every shareholder they will have a exit price.

Remember every billion Avacta SP rises that’s £4 per share x 11 million for them.

1 Billion = £44million
2 Billion = £88million
3 Billion = £132million
4 Billion = £176 million
5 Billion = £220million
So a £5 billion takeover which is achievable given Avacta’s pipeline gives them a profit of £220 million a 1/6 of the value of Boohoo.
DYOR

Has Avacta asked for a place for him on the board to oversee the precision trial .
I remember Gates foundation placed one of their guys on the Mologic board.
Just a thought …..

The partnership will provide a faster route to market for Avacta’s rapid antigen test by CE marking it for professional use under Mologic’s existing ISO13485 quality system.

Now Mologic haven’t had anything out of this partnership yet, watch this space Gates foundation bought Mologic after this announcement.
FDA clearance for a cheaper saliva test perhaps.

https://mologic.co.uk/avacta-and-mologic-announce-commercial-partnership/

DYOR
So many shots on goal with Avacta.

Therapeutic Division
Oncology x 11
Ava6000,AVA7500,
AVA028,AVA7000,AVA004
AVA027,AVA3996 plus 4 undisclosed targets
Not forgetting T Mac platform.
Diagnostics Division
Medusa19 Global agreement Meduflow HUA
Affidx, Bams,Elisa,
Plus in house pipe line non-COVID diagnostic tests, which include assays for D-dimer, cortisol, vitamins D and B12 and CRP.

Partnerships

LG Chem x 8
Every RNS states a multi-target deal with LG Chem worth up to $400m.
LG Chem has potentially 8 new products.
multi-target collaboration with LG Chem incorporating Avacta's Affimer XT™ serum half-life extension and LG Chem has Affimer PD-L1 inhibitortotalling $98million
The expanded partnership also provides LG Chem with rights to develop and commercialise other Affimer and non-Affimer biotherapeutics combined with Affimer XT half-life extension for a range of indications and Avacta could earn an additional $55m in milestone payments for each of these new products.
Daewoong x 2
Gene & stem cell with other targets
Point
radiopharmaceutical prodrugs
Moderna x 1
exclusive license agreement with respect to certain Affimer molecules
Astrea x 1
Deepverge x 1
Biokit x 1
Abcam x 1
Bioserve x 1

And Mologic partnership mentioned above.

Look who has just joined Point Bio Board just as they are about to trial a can seek drug using Tufts and Avacta pre Cision technology.
8% rise in share price on the back of this announcement.

https://finance.yahoo.com/news/point-biopharma-adds-senior-bd-133000274.html

2022 will see some big news for Avacta.

Agile took all PCR off their website and for testing just have Medusa’s favourite two words:
COMING SOON
https://www.agilelifesciences.com/covid-19-travel-testing

See the FDA are still working between Christmas & New year to pass tests in a pandemic.
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2

Not like our lazy civil servants who won’t be back until tomorrow.

Over 100k cases a day for 12 consecutive days in England.
Shocking that they are showing no urgency to pass more tests.

The Cambridge and Yorkshire company Avacta had to suspend sales of its AffiDX antigen test in November because it had not yet passed the new CDTA checks despite being entered for it before a September deadline. It has yet to be given the go-ahead in Britain. It was the first UK-developed test to be CE certified for consumer self-testing last month but can only be sold abroad.

What is the doom brigade crying about:

The paragraph in the Times about Avacta is what we all already know and has been RNS’s
AS has stated numerous occasions he has set his sights on Europe and the rest of the world.
Relax and chill

And it’s AVA3996

This report saying Surescreen could have a capacity of 14 million per week end of December,but are reliant on ODX.
ODX closed for Xmas and a big sour taste with their cancelled contract, let’s see what happens in the morning….

https://www.gov.uk/government/news/first-uk-manufactured-rapid-tests-deployed-across-england

A
V ery
A wsome
C hristmas
T o
A ll

OK I have posted this a few times but now but we now have HUA and Meduflow is real here we go again….
Medusa have been working optimising their website with Venn digital , who also have built the Saturn pass mobile App platform .So they are getting ready for a USA launch.

Sub-folder URL structures for a website, mean anything after the .com or .com/uk/, depending on what your set-up is.
For example, with our clients Medusa 19, we've gone down the localised translated route.

The Saliva test has been dropped now for Meduflow.

https://www.venndigital.co.uk/blog/expanding-into-the-usa-recruitment-boom-venns-international-seo-checklist-275507/

They have also been using the services of another company.
https://www.covidrapidexam.com/

I have posted this before that I filled out the contact form and received this reply straight away.

Message:
Hi ?Are you supplying Medusa antigen test by Avacta (Affidx)?If so when and is it being sold in USA?Regards?Bill

Re: Form Submission - Covid Rapid Exam Form

stevecrummey**********

Thanks Bill. We will have FDA approval within 45-60 days.
That was dated 9th Nov 2021

DYOR
Why would a company spend multi millions of pounds and put reputations on line for zero return.
Both Boohoo founders have their children with massive shareholdings in Avacta.

Just hold your shares and secure your family futures,
Once in a life time investment and new share holders can get in less than some Long term Holders.

Merry Christmas